GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AcuCort AB (XSAT:ACUC) » Definitions » Float Percentage Of Total Shares Outstanding

AcuCort AB (XSAT:ACUC) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 26, 2024)


View and export this data going back to 2017. Start your Free Trial

What is AcuCort AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, AcuCort AB's float shares is 0.00 Mil. AcuCort AB's total shares outstanding is 84.01 Mil. AcuCort AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, AcuCort AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, AcuCort AB's Institutional Ownership is 0.00%.


AcuCort AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

AcuCort AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/84.01
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AcuCort AB (XSAT:ACUC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AcuCort AB (XSAT:ACUC) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
N/A
Address
Kullagatan 8, Helsingborg, SWE, 252 20
AcuCort AB is an innovative biotechnology company that identifies, develops and commercializes smart drugs that meet the patient's needs for a user-friendly and effective treatment.

AcuCort AB (XSAT:ACUC) Headlines

No Headlines